Johnson & Johnson Innovative Medicine News and Activities

Johnson & Johnson Innovative Medicine is owned by Johnson & Johnson.

Johnson & Johnson is one of the...

• Forbes Global 2000 (#42);
• Fortune 500 (#45);
• Global Fortune 500 (#131);
• Russell 3000;
• S&P 500;
• TOB Iconic 10,000.

Johnson & Johnson is a company listed under the stock ticker JNJ (US).

Johnson & Johnson has a direct presence in 23 countries.

Johnson & Johnson has 56 subsidiaries including Abiomed, DePuy Synthes and Ethicon.

They are in:

• Pharmaceuticals61%
• Medical Equipment19%
• Other19%

Acquisition, funding and merger involving Johnson & Johnson.

• Firefly Bio and Johnson & Johnson have announced they will merge  (posted on June 8 2026)..
• Johnson & Johnson has announced the acquisition of Intra-Cellular Therapies  (posted on January 13 2025).
• Johnson & Johnson has acquired V-Wave (posted on October 9 2024).

View the org chart displaying its 133 main executives

Most searched biographies at Johnson & Johnson Innovative Medicine

• Jennifer Taubert, Executive Vice President, Worldwide Chairman, Ph...
• Nauman Shah, Global Head, Business Development
• Sarah Brennan, Company Group Chairman, Global Commercial Strategy ...

Popular executive movements at Johnson & Johnson Innovative Medicine

• Kristin Schuhwerk, who was Senior Vice President, Global Head, R&D Strategy, Portfolio & Operations, is promoted to Senior Vice President, Head of Global Development  (posted on February 24 2026).
• Howard Furman who was Head, Talent Management and Innovative Medicine, becomes Head of Human Resources, Innovative Medicine Supply Chain Plan and Deliver  (posted on January 28 2026).

Popular executive movements at Johnson & Johnson

• Ryan Koors will join the company as Vice President, Investor Relations on May 6, 2026  (posted on April 30 2026).
• Lauren Johnson, who was Senior Director, Investor Relations, is promoted to Chief Financial Officer, External Innovation Finance  (posted on February 26 2026).
• Geetanjali Gamel, who was Head of Human Resources, Global Commercial Strategy and Business Development, is promoted to Head of Human Resources, US Surgery  (posted on January 5 2026).

Click here to view some more movements at Johnson & Johnson

Create your alert
to follow the executive moves at Johnson & Johnson Innovative Medicine.

Johnson & Johnson has 1,914 competitors including Sanofi (France), Moderna (United States (USA)) and Eli Lilly (United States (USA)).

Popular M&A news in Pharmaceuticals

• The new name of Stealth BioTherapeutics is Mighty Therapeutics. (posted on June 19 2026).
• Transcend has announced the acquisition of Otsuka America Pharmaceutical  (posted on June 18 2026).
• Chiesi has announced the acquisition of Kalvista Pharmaceuticals  (posted on June 18 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Tracey Franklin - Chief People and Digital Technology Officer at Moderna
• Richard Saynor - Chief Executive Officer at Sandoz

Learn more about the Pharmaceuticals industry

Press releases by Johnson & Johnson Innovative Medicine

• Media contacts
• Blogs
• Newsroom
• Johnson & Johnson Releases its 2022 Health for Humanity Report and We All Belong: 2022 DEI Impact Review
• Johnson & Johnson Named a 2023 Fortune World’s Most Admired Company and Ranked #1 on the Pharmaceutical Industry List
• Centre d'actualités >
• Home | Janssen
• Home | Janssen
• Home | Janssen
• Home | Janssen
• View more press releases Close

Social media about Johnson & Johnson Innovative Medicine

• Johnson & Johnson Innovative Medicine on Wikipedia, Google News & Yahoo Finance
• Johnson & Johnson Innovative Medicine on LinkedIn, X (Twitter) & YouTube